If reduced PNPLA3 activity was to accelerate NAFLD, Pnpla3 knockout mice would be expected to have severely fatty livers; however, in fact, they have no evidence of NAFLD (109). Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.